News

Gilead’s former general counsel — key to drug maker’s battle against Covid, HIV and hepatitis C — lands at Peninsula law firm

Brett Pletcher spent nearly 18 years at Gilead during the company’s biggest expansion stage to a multibillion-dollar drug maker. Click here to view original post Click here to view San Francisco Biotech Networks Trending News

News

Positive Phase III Results for Genentech’s Ocrevus (ocrelizumab) Twice a Year, 10-Minute Subcutaneous Injection in Patients With Multiple Sclerosis

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase III OCARINA II trial evaluating Ocrevus® (ocrelizumab) as a twice a year 10-minute subcutaneous […]

News

Tenpoint Therapeutics launches with $70M to restore vision with stem cell therapies and ‘reprogramming’ medicines

Although numerous biotech companies are developing gene therapies to correct eyesight, these approaches largely require the affected cells to remain intact — while many forms of vision loss are caused by dead or dying cells. […]